Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CBER/CDER electronic submissions workshop in September will focus on modifying case report forms.

Executive Summary

CBER/CDER ELECTRONIC CASE REPORT WORKSHOP SLATED FOR SEPTEMBER will concentrate on modification of case report forms into an electronic format, the Center for Biologics Evaluation & Research's Mary Buesing, MD, stated July 11 at a gene therapy workshop sponsored by the agency and the National Cancer Institute in Bethesda, Md. The planned autumn workshop, to be co-sponsored by the Drug Information Association, aims to "have industry involvement," Buesing noted. CBER and the Center for Drug Evaluation & Research also plan to release an Federal Register notice on the planned electronic format "as early as December this year," Buesing said.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel